EMVision Medical Devices Ltd

Equities

EMV

AU0000028375

Advanced Medical Equipment & Technology

Delayed Australian S.E. Other stock markets 01:58:09 2024-04-24 am EDT			5-day change	1st Jan Change
2.2 ^AUD	-2.65%		-3.51%	+29.79%

Feb. 29	EMVision Medical Devices Secures AU$15.28 Million Investment from Keysight Technologies	MT
Feb. 29	EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	CI

EMvision Medical Devices Limited Reports Audited Earnings Results for the Nine Months Ended April 30, 2018

December 11, 2018 at 01:34 am EST

EMvision Medical Devices Limited reported audited earnings results for the nine months ended April 30, 2018. For the year the company reported grant income of AUD 401,000, loss after income tax expense for the period and total comprehensive loss for the period were AUD 404,765 and basic loss per share of 2.202 cents.

Latest news about EMVision Medical Devices Ltd

EMVision Medical Devices Secures AU$15.28 Million Investment from Keysight Technologies	Feb. 29	MT
EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 29	CI
EMVision Medical Devices Ltd announced that it expects to receive AUD 15.281174 million in funding from Keysight Technologies, Inc.	Feb. 27	CI
EMVision Medical Devices Secures Nearly AU$3 Million R&D Tax Rebate for Fiscal Year 2023	Dec. 17	MT
EMVision Medical Devices Enrolls 150 Patients for Brain Scanner Trials	Nov. 28	MT
EMVision Medical Devices Assembles 28-Antenna Prototype of Helmet Scanner; Shares Jump 12%	23-10-24	MT
Emvision Reports Positive Interim Results from Stage II Trial of Stroke Detection Algorithm	23-10-11	MT
EMVision Medical Devices Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29	CI
Emvision Medical Begins Enrollment at Second Site for Portable Brain Scanner Stage Two Trial	23-06-28	MT
Emvision Medical Devices Limited Receives $1.75 Million Manufacturing Grant Award	23-06-12	CI
Emvision Medical Devices Appoints CEO	23-05-30	MT
EMVision Medical Devices Ltd. Announces Leadership Transition, Effective July 1, 2023	23-05-30	CI
EMVision Medical Devices Ltd. Appoints Forough Khandan as Chief Technology Officer	23-05-30	CI
EVision Medical Devices Begins Stage 2 Clinical Trial for Portable Brain Scanner	23-05-28	MT
EMVision Medical Devices Limited Appoints Professor Alan Coulthard to Clinical Advisory Board	23-03-13	CI
EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-27	CI
EMVision Medical Devices Completes Enrollment for Stage 1 Clinical Trial for Brain Scanning Technology	23-02-20	MT
EMVision Medical Devices Ltd Completes Clinical Trial Stage 1 Enrolment	23-02-20	CI
EMVision Medical Devices Advances Clinical Trial for Portable Brain Scan Device, Secures Grant Funding Milestone	23-01-25	MT
EMVision Medical Devices Limited Provides an Update on Its Clinical Trial and Achievement of an Important Technical Development Milestone	23-01-24	CI
EMVision Medical Devices Secures R&D Tax Refund for FY22	22-11-30	MT
Emvision Medical Devices Starts First Stage of Multicenter Clinical Trial; Shares Up 3%	22-11-29	MT
EMVision Commences Clinical Trial	22-11-29	CI
EMVision Medical Devices Advances Development of Portable Brain Scanner with Clinical Trial Delivery; Shares Rally 16%	22-11-13	MT
EMVision Medical Devices Ltd Announces its Portable Brain Scanner Delivered to First Clinical Site	22-11-13	CI

Chart EMVision Medical Devices Ltd

Duration

Period

More charts

Company Profile

EMVision Medical Devices Limited is an Australia-based medical device company developing an approach to looking inside the human body. The Company is engaged in the research and development of medical imaging and diagnostic technology (the EMVision Technology), for the purpose of commercializing a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs. The Company is developing and commercializing medical imaging diagnostics for various disease states and medical emergencies. The Companyâs product pipeline includes portable, non-invasive, neuroimaging devices. Its lead product in development includes a portable, non-ionizing brain scanner, capable of producing images of biological tissue to provide insights for clinicians. Its second-generation device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
EMVISION MEDICAL DEVICES LTD	+29.79%	125M
THERMO FISHER SCIENTIFIC	+8.78%	219B
DANAHER CORPORATION	+8.24%	187B
INTUITIVE SURGICAL, INC.	+11.16%	134B
BOSTON SCIENTIFIC CORPORATION	+26.12%	101B
SIEMENS HEALTHINEERS AG	+0.30%	62.27B
EDWARDS LIFESCIENCES CORPORATION	+16.21%	52.82B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.63%	47.49B
AGILENT TECHNOLOGIES, INC.	-1.11%	40.79B
GE HEALTHCARE TECHNOLOGIES INC.	+12.16%	39.35B

Other Advanced Medical Equipment & Technology